Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1aCondition 1b
850Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89body massRS:0000239DA/Bklboth126 days to 66 days105CMO:0001399body weight loss(weight loss)19%0.4885.0MMO:0000016body weighing method0.0variableimmunized10daystype II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 69960type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
3077Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.body massRS:0000239DA/Bklmale95 days to 89 days9CMO:0001400maximum body weight loss to initial body weight ratio4.7%1.03.0MMO:0000016body weighing method0.0arterial catheter implantation1daysarterial catheter implantation (for 1 days)107183arterial catheter implantation (for 1 days)
1299Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44.joint integrity traitRS:0000239DA/Bklmale126 days to 63 days15CMO:0001453percentage of study population developing experimental arthritis during a period of time100%MMO:0000163in vivo visual assessment3024000.0type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 70146type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
1299Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44.joint integrity traitRS:0000239DA/Bklfemale126 days to 63 days14CMO:0001453percentage of study population developing experimental arthritis during a period of time100%MMO:0000163in vivo visual assessment3024000.0type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 70147type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
1158Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11joint integrity traitRS:0000239DA/Bklmale105 days to 77 days10CMO:0001453percentage of study population developing experimental arthritis during a period of time50%MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (0.1 ml) 69551Freund's incomplete adjuvant (0.1 ml)
1158Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11joint integrity traitRS:0000239DA/Bklmale105 days to 77 days12CMO:0001453percentage of study population developing experimental arthritis during a period of time83.3%MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (0.1 ml) 69552Freund's incomplete adjuvant (0.1 ml)
850Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89joint integrity traitRS:0000239DA/Bklboth126 days to 66 days105CMO:0001453percentage of study population developing experimental arthritis during a period of time100%MMO:0000163in vivo visual assessment0.0variableimmunized10daystype II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 69959type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
1158Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11joint integrity traitRS:0000239DA/Bklmale105 days to 77 days10CMO:0001453percentage of study population developing experimental arthritis during a period of time0%MMO:0000163in vivo visual assessment0.00.9% sodium chloride solution (0.1 ml) 970700.9% sodium chloride solution (0.1 ml)
1158Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11joint integrity traitRS:0000239DA/Bklmale105 days to 77 days12CMO:0001453percentage of study population developing experimental arthritis during a period of time0%MMO:0000163in vivo visual assessment0.00.9% sodium chloride solution (0.1 ml) 970710.9% sodium chloride solution (0.1 ml)
850Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89joint integrity traitRS:0000239DA/Bklboth126 days to 66 days105CMO:0001450post-insult time to onset of experimental arthritis15d0.19522.0MMO:0000163in vivo visual assessment0.0variableimmunized10daystype II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 68143type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
1158Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11joint integrity traitRS:0000239DA/Bklmale105 days to 70 days12CMO:0001450post-insult time to onset of experimental arthritis15.8d3.311.4315MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (0.1 ml) 69553Freund's incomplete adjuvant (0.1 ml)
1158Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11joint integrity traitRS:0000239DA/Bklmale105 days to 70 days10CMO:0001450post-insult time to onset of experimental arthritis14.4d1.34.111MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (0.1 ml) 69554Freund's incomplete adjuvant (0.1 ml)
850Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89blood immunoglobulin amountRS:0000239DA/Bklboth126 days to 66 days105CMO:0001278calculated serum anti-porcine type 2 collagen antibody titertiter190.58556.0MMO:0000075enzyme linked immunosorbent assay0.0variableimmunized10daystype II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 69962type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
970Potenza MN, et al., Biol Psychiatry 2004 Mar 15;55(6):634-41.blood corticosterone amountRS:0000239DA/Bklmale0 days11CMO:0001173plasma corticosterone level47.39ng/ml10.7735.72MMO:0000073radioimmunoassay0.0controlled exposure to ambient light (for 12 hours)68639controlled exposure to ambient light (for 12 hours)
850Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89blood autoantibody amountRS:0000239DA/Bklboth126 days to 66 days105CMO:0001281calculated serum anti-rat type 2 collagen autoantibody titertiter150.58556.0MMO:0000075enzyme linked immunosorbent assay0.0variableimmunized10daystype II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) 69963type II collagen (2 mg/kg) Freund's incomplete adjuvant (50 %)
3077Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.drinking behavior traitWater consumed (g) postsurgery per 100 g BWRS:0000239DA/Bklmale95 days to 89 days9CMO:0002859water intake drink rate to body weight ratio0.98ml/d/kg0.180.54MMO:0000619drink intake measuring method0.0arterial catheter implantation1daysarterial catheter implantation (for 1 days)107162arterial catheter implantation (for 1 days)

Contact Us |  About Us |  Jobs at RGD